May 22 2025
New Novo Nordisk initiatives support patient access to authentic, FDA-approved Wegovy® as federal ban on mass compounding of "semaglutide" takes effect
Read more
May 13 2025
In new SELECT trial analysis, early reduction in cardiovascular events was observed with Wegovy®, before clinically meaningful changes in body weight
Read more
May 07 2025
Novo Nordisk's sales increased by 19% in Danish kroner and by 18% at constant exchange rates to USD 11.0 billion in the first three months of 2025
Read more
Here are our current job openings. If we don’t currently have an opening in your area of interest, we encourage you to create a job agent and candidate profile.
We offer 866 job opportunities